Does DEXLANSOPRAZOLE Cause Salivary hypersecretion? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Salivary hypersecretion have been filed in association with DEXLANSOPRAZOLE (Dexlansoprazole). This represents 0.0% of all adverse event reports for DEXLANSOPRAZOLE.
6
Reports of Salivary hypersecretion with DEXLANSOPRAZOLE
0.0%
of all DEXLANSOPRAZOLE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Salivary hypersecretion From DEXLANSOPRAZOLE?
Of the 6 reports, 1 (16.7%) required hospitalization.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEXLANSOPRAZOLE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does DEXLANSOPRAZOLE Cause?
Chronic kidney disease (15,973)
Acute kidney injury (7,599)
Renal failure (6,618)
End stage renal disease (4,800)
Renal injury (4,320)
Tubulointerstitial nephritis (2,177)
Death (1,417)
Rebound acid hypersecretion (1,160)
Gastrooesophageal reflux disease (1,013)
Drug ineffective (859)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which DEXLANSOPRAZOLE Alternatives Have Lower Salivary hypersecretion Risk?
DEXLANSOPRAZOLE vs DEXMEDETOMIDINE
DEXLANSOPRAZOLE vs DEXMETHYLPHENIDATE
DEXLANSOPRAZOLE vs DEXMETHYLPHENIDATE\SERDEXMETHYLPHENIDATE
DEXLANSOPRAZOLE vs DEXPANTHENOL
DEXLANSOPRAZOLE vs DEXRAZOXANE